U.S. Food and Drug Administration

Collage of images including drug vials with syringe, 3D rendering of coronavirus, and closeup of a person being administered a shot

Featured

FDA Takes Action to Address Coronavirus Disease 2019 (COVID-19)

FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Jun 24

Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19

Jun 24

FDA In Brief: FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies

More Press Announcements

Newsroom Meetings Testimony Speeches

Jun 21

Prairie Wolf Spirits, Inc. Issues Voluntary Nationwide Recall of Prairie Wolf Distillery Hand Sanitizer Packed in 16.9 Oz. and 20 Oz Bottles Because They Resemble Drink Containers

Drugs

Jun 21

Bea Lydecker’s Naturals, Inc. Issues Allergy Alert on Undeclared Soy Lecithin in Living Free Dietary Supplement

Food & Beverages

Jun 19

Cuisine Solutions Issues Voluntary Recall of Flavored Plant-Based Bites

Food & Beverages

Paragraph Header

FDA’s Budget: Maternal and Infant Health and Nutrition

FDA’s FY 2022 budget includes important funding to core food safety programs and emerging issues of concern such as maternal and infant health and nutrition.

FDA Budget Fiscal Year 2022. Top image of medical icons. Left image of pill bottles with one bottle fallen over spilling pills. Right image of FDA inspector checking pharmaceuticals. Bottom image of opioid pills.

FDA’s Budget: Advancing the Goal of Ending the Opioid Crisis

FDA’s FY 2022 budget would address current public health needs and help FDA to tackle complex challenges such as those needed in addressing the opioid crisis.

two image collage, including photo of a research scientist in the lab looking into microscope and an electron micrograph of three stem cells

A research scientist looking into a microscope, and an electron micrograph of stem cells, color-enhanced for visual clarity.

Innovative Regenerative Medicine Therapies – Patient Safety Comes First

Cellular-derived therapies offer the potential to treat or even cure diseases or conditions for which few effective treatment options exist.

More FDA Voices

Jun 25

Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies

Biologics, Drugs

Jun 24